Joseph J. Manning, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 2,207 shares at $44.96 ($100K) on 2017-02-28, disclosed to the SEC on 2017-03-02.
Scheduled sale ($100k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.96 | 1 | $45 | 0.0% |
| 2 | $44.96 | 56 | $3K | 2.5% |
| 3 | $44.96 | 300 | $13K | 13.5% |
| 4 | $44.96 | 387 | $17K | 17.4% |
| 5 | $45.46 | 1,463 | $67K | 66.5% |
| Total | $45.29 avg | 2,207 |
| $100K |
| 100% |
| Filing → |
| ABT | SELL | 2022-08-26 | $5.6M | — | Filing → |
| ABT | SELL | 2022-03-02 | $184K | — | Filing → |
| ABT | SELL | 2021-02-03 | $5.4M | — | Filing → |